Date Milestone Abstract
2013-04   The company's capital increased to NT$95 millions.
2011-07  

The company's capital increased to NT$88 millions.

2010-07

Invested in Salutor Co., Ltd.

 

Salutor became the sole distributor of products in Taiwan.

 

The company's capital increased to NT$80 millions.

2009-07  

The company's capital increased to NT$75 millions.

2008-10

Became sole distributor of  endoscopes in Taiwan.

 

endoscope business is integrated to  medical systems business division on Oct. 1, 2008.

 

The company's capital increased to NT$68 millions.

2007-09 Invested in "gene chip application plan" with Welgene Biotech through Economy Department plan of special case

Welmore and Welgene Biotech invested in "gene chip application plan-nucleic acids purification service medicament development" through Economy Department plan of special case subsidy.

 

The company's capital increased to NT$60 millions.

2006-6   Welmore increased the paid-in capital to NT$ 50 millions.
2004-12 Set up Taichung and Kaohsiung branches Welmore set up branch office in Taichung and Kaohsiung.
Raised the paid-in capital to NT$38 millions.
2004-08 Became sole distributor in Endoscope field is the subsidy of , Japan.
Welmore obtained the sole distributorship of Endoscopes in Taiwan.
2003-09 Moveed headquarters to NanKang Software Park Moved to NKSP for better industrial clustering effect.
2002-10 Started providing medical device sales & service business Started our business in distributing medical devices & services. Raised paid-in capital to NT$20 millions.
2001-12 Established Welmore established with paid-in capital of NT$10 millions.

About Us
Entrepreneur Concept
Main Business
Milestone
Location